PRMT-5 inhibitors (MSD)

N/A

Report date: 2025/06/11 11:19:43
NME

Base Information

Drug NamePRMT-5 inhibitors (MSD)
Drug Alias NamePRMT-5 inhibitors (Cancer Therapeutics CRC)protein arginine N-methyltransferase 5 inhibitors (Cancer Therapeutics CRC)CTx-0262135CTx-0391034CTx-393293 +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsHematologic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme （Australia） Pty Ltd
Inactive CompaniesCancer Therapeutics CRC Pty LtdCancer Research TechnologyWalter And Eliza Hall Institute Of Medical Research
Active IndicationsHematologic DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A